Loading...

We've got a brand new version of Simply Wall St! Try it out

LeanLife Health

CNSX:LLP
Snowflake Description

Worrying balance sheet with weak fundamentals.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
LLP
CNSX
CA$5M
Market Cap
  1. Home
  2. CA
  3. Food, Beverage & Tobacco
Company description

LeanLife Health Inc. produces and sells omega-3 fatty acid products in North America, Europe, and internationally. The last earnings update was 20 days ago. More info.


Add to Portfolio Compare Print
LLP Share Price and Events
7 Day Returns
0%
CNSX:LLP
-0.6%
CA Food
1.2%
CA Market
1 Year Returns
10%
CNSX:LLP
-1.6%
CA Food
-0.2%
CA Market
LLP Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
LeanLife Health (LLP) 0% 10% -8.3% 10% -45% -
CA Food -0.6% -1.3% 0.1% -1.6% -6.8% 26%
CA Market 1.2% 4.2% 1.5% -0.2% 8.4% 1.8%
1 Year Return vs Industry and Market
  • LLP outperformed the Food industry which returned -1.6% over the past year.
  • LLP outperformed the Market in Canada which returned -0.2% over the past year.
Price Volatility
LLP
Industry
5yr Volatility vs Market

LLP Value

 Is LeanLife Health undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
  • It is not possible to calculate the future cash flow value for LeanLife Health. This is due to cash flow or dividend data being unavailable. The share price is CA$0.055.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for LeanLife Health's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are LeanLife Health's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
CNSX:LLP PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2019-06-30) in CAD CA$-0.03
CNSX:LLP Share Price ** CNSX (2019-09-11) in CAD CA$0.06
Canada Food Industry PE Ratio Median Figure of 12 Publicly-Listed Food Companies 20.74x
Canada Market PE Ratio Median Figure of 538 Publicly-Listed Companies 14.15x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of LeanLife Health.

CNSX:LLP PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= CNSX:LLP Share Price ÷ EPS (both in CAD)

= 0.06 ÷ -0.03

-1.57x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • LeanLife Health is loss making, we can't compare its value to the CA Food industry average.
  • LeanLife Health is loss making, we can't compare the value of its earnings to the Canada market.
Price based on expected Growth
Does LeanLife Health's expected growth come at a high price?
Raw Data
CNSX:LLP PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section -1.57x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 0 Analysts
Not available
Canada Food Industry PEG Ratio Median Figure of 5 Publicly-Listed Food Companies 0.6x
Canada Market PEG Ratio Median Figure of 246 Publicly-Listed Companies 0.98x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for LeanLife Health, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on LeanLife Health's assets?
Raw Data
CNSX:LLP PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2019-06-30) in CAD CA$0.00
CNSX:LLP Share Price * CNSX (2019-09-11) in CAD CA$0.06
Canada Food Industry PB Ratio Median Figure of 28 Publicly-Listed Food Companies 2x
Canada Market PB Ratio Median Figure of 2,452 Publicly-Listed Companies 1.44x
CNSX:LLP PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= CNSX:LLP Share Price ÷ Book Value per Share (both in CAD)

= 0.06 ÷ 0.00

97x

* Primary Listing of LeanLife Health.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • LeanLife Health is overvalued based on assets compared to the CA Food industry average.
X
Value checks
We assess LeanLife Health's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Food industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Food industry average (and greater than 0)? (1 check)
  5. LeanLife Health has a total score of 0/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

LLP Future Performance

 How is LeanLife Health expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as LeanLife Health has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have past financial data. You can see them here.

Show me the analysis anyway

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
7.2%
Expected Food industry annual growth in earnings.
Earnings growth vs Low Risk Savings
Is LeanLife Health expected to grow at an attractive rate?
  • Unable to compare LeanLife Health's earnings growth to the low risk savings rate as no estimate data is available.
Growth vs Market Checks
  • Unable to compare LeanLife Health's earnings growth to the Canada market average as no estimate data is available.
  • Unable to compare LeanLife Health's revenue growth to the Canada market average as no estimate data is available.
Annual Growth Rates Comparison
Raw Data
CNSX:LLP Future Growth Rates Data Sources
Data Point Source Value (per year)
Canada Food Industry Earnings Growth Rate Market Cap Weighted Average 7.2%
Canada Food Industry Revenue Growth Rate Market Cap Weighted Average 5.6%
Canada Market Earnings Growth Rate Market Cap Weighted Average 12.6%
Canada Market Revenue Growth Rate Market Cap Weighted Average 6%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
CNSX:LLP Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (2 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
All numbers in CAD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
CNSX:LLP Past Financials Data
Date (Data in CAD Millions) Revenue Cash Flow Net Income *
2019-06-30 -2 -3
2019-03-31 -2 -3
2018-12-31 -2 -2
2018-09-30 -2 -3
2018-06-30 -2 -2
2018-03-31 -2 -2
2017-12-31 -1 -2
2017-09-30 -1 -1
2017-06-30 -1 -1
2017-03-31 -1 -1
2016-12-31 -1 -4
2016-09-30 -1 -4

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Unable to determine if LeanLife Health is high growth as no earnings estimate data is available.
  • Unable to determine if LeanLife Health is high growth as no revenue estimate data is available.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
CNSX:LLP Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (2 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below

All data from LeanLife Health Company Filings, last reported 2 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

CNSX:LLP Past Financials Data
Date (Data in CAD Millions) EPS *
2019-06-30 -0.03
2019-03-31 -0.04
2018-12-31 -0.04
2018-09-30 -0.05
2018-06-30 -0.05
2018-03-31 -0.06
2017-12-31 -0.06
2017-09-30 -0.04
2017-06-30 -0.04
2017-03-31 -0.03
2016-12-31 -0.09
2016-09-30 -0.10

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if LeanLife Health will efficiently use shareholders’ funds in the future without estimates of Return on Equity.

Next steps:

  1. Take a look at our analysis of LLP’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  2. LeanLife Health's future outlook can be gauged by looking at industry trends and market size, and determining how well-positioned the company is compared to its competitors. Take a look at other high-growth Food, Beverage & Tobacco companies here
  3. LeanLife Health's competitive advantages and company strategy can generally be found in its financial reports archived here.
  4. Use fundamentals to screen for another stock to analyse from our database of over 75,000 companies worldwide
X
Future performance checks
We assess LeanLife Health's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Canada market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Canada market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
LeanLife Health has a total score of 0/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

LLP Past Performance

  How has LeanLife Health performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare LeanLife Health's growth in the last year to its industry (Food).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • LeanLife Health does not make a profit and their year on year earnings growth rate was negative over the past 5 years.
  • Unable to compare LeanLife Health's 1-year earnings growth to the 5-year average as it is not currently profitable.
  • Unable to compare LeanLife Health's 1-year growth to the CA Food industry average as it is not currently profitable.
Earnings and Revenue History
LeanLife Health's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from LeanLife Health Company Filings, last reported 2 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

CNSX:LLP Past Revenue, Cash Flow and Net Income Data
Date (Data in CAD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2019-06-30 -2.70 2.22 0.07
2019-03-31 -2.72 2.24 0.06
2018-12-31 -2.18 1.58 0.09
2018-09-30 -2.65 2.06 0.09
2018-06-30 -2.30 1.85 0.09
2018-03-31 -2.36 1.90 0.12
2017-12-31 -2.25 1.84 0.09
2017-09-30 -1.30 1.08 0.07
2017-06-30 -1.29 1.05 0.07
2017-03-31 -0.98 0.78 0.03
2016-12-31 -4.20 0.82 0.03
2016-09-30 -4.05 0.68 0.03
2016-06-30 -3.91 0.58 0.03
2016-03-31 -3.73 0.42 0.01
2015-12-31 -0.33 0.28
2015-09-30 -0.35 0.30
2015-06-30 -0.33 0.28
2015-03-31 -0.31 0.25
2014-03-31 -0.01 0.01

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • It is difficult to establish if LeanLife Health has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.
  • It is difficult to establish if LeanLife Health has efficiently used its assets last year compared to the CA Food industry average (Return on Assets) as it is loss-making.
  • It is difficult to establish if LeanLife Health improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
X
Past performance checks
We assess LeanLife Health's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Food industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
LeanLife Health has a total score of 0/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

LLP Health

 How is LeanLife Health's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up LeanLife Health's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • LeanLife Health's short term (1 year) commitments are greater than its holdings of cash and other short term assets.
  • LeanLife Health has no long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of LeanLife Health's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • High level of physical assets or inventory.
  • Debt is covered by short term assets, assets are 1.3x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from LeanLife Health Company Filings, last reported 2 months ago.

CNSX:LLP Past Debt and Equity Data
Date (Data in CAD Millions) Total Equity Total Debt Cash & Short Term Investments
2019-06-30 0.05 0.19 0.00
2019-03-31 0.27 0.13 0.03
2018-12-31 -0.23 0.08 0.01
2018-09-30 -0.26 0.31 0.03
2018-06-30 0.02 0.08 0.00
2018-03-31 0.37 0.07 0.05
2017-12-31 0.84 0.13 0.81
2017-09-30 -0.33 0.18 0.00
2017-06-30 -0.20 0.05 0.00
2017-03-31 0.02 0.06 0.18
2016-12-31 -0.12 0.04 0.02
2016-09-30 -0.81 0.12 0.00
2016-06-30 -0.64 0.11 0.00
2016-03-31 -0.44 0.11 0.00
2015-12-31 -0.04 0.11 0.00
2015-09-30 0.09 0.02 0.01
2015-06-30 0.12 0.02 0.05
2015-03-31 0.15 0.02 0.07
2014-03-31 0.00 0.01 0.00
  • LeanLife Health's level of debt (345%) compared to net worth is high (greater than 40%).
  • The level of debt compared to net worth has increased over the past 5 years (23.1% vs 345% today).
CASH RUNWAY ANALYSIS

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

  • LeanLife Health has less than a year of cash runway based on current free cash flow.
  • LeanLife Health has less than a year of cash runway if free cash flow continues to grow at historical rates of 39.7% each year.
X
Financial health checks
We assess LeanLife Health's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. LeanLife Health has a total score of 1/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

LLP Dividends

 What is LeanLife Health's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from LeanLife Health dividends.
If you bought CA$2,000 of LeanLife Health shares you are expected to receive CA$0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate LeanLife Health's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate LeanLife Health's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
CNSX:LLP Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
Canada Food Industry Average Dividend Yield Market Cap Weighted Average of 9 Stocks 1.9%
Canada Market Average Dividend Yield Market Cap Weighted Average of 333 Stocks 3.5%
Canada Minimum Threshold Dividend Yield 10th Percentile 1.2%
Canada Bottom 25% Dividend Yield 25th Percentile 2%
Canada Top 25% Dividend Yield 75th Percentile 5.8%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as LeanLife Health has not reported any payouts.
  • Unable to verify if LeanLife Health's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of LeanLife Health's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as LeanLife Health has not reported any payouts.
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess LeanLife Health's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 1.2%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can LeanLife Health afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. LeanLife Health has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

LLP Management

 What is the CEO of LeanLife Health's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Stan Lis
COMPENSATION CA$354,969
AGE 68
TENURE AS CEO 4 years
CEO Bio

Mr. Stanislaw L. Lis, also known as Stan, has been Chief Executive Officer and President of Leenlife Pharma International Inc. (also known as SPT - Sulphur Polymer Technologies Inc) since September 2015. Mr. Lis co-founded MicroCoal Technologies Inc. in 2006 and served as its President until February 13, 2014. Mr. Lis served as the Chief Executive Officer of La Jolla Capital Inc. (formerly known as MicroCoal Technologies Inc.) until June 23, 2011. Mr. Lis served as the Chief Executive Officer and President of Net Soft Systems Inc. He served as the President of Stream Communications Network & Media Inc. from February 25, 1994 to August 15, 2005 and Chief Executive Officer from April 23, 1999 to August 15, 2005. He served as Member of Supervisory Board of Stream Communications Sp z o o. He served as President and Chief Executive Officer Director of Trooper Technologies Inc. from 1993 to 2000. He served as President of Avigo Resources Corp. Since April 23, 1999, he has also been performing the function of Chief Executive Officer. He commenced his education in Poland. At the beginning of the 1980s he worked in the finance economy department of AllCorp. In 1988 he founded International UNP Holdings and served as its President from 1989 to 1992. In 1992, he created a joint venture company with the participation of the American company Emergency One and WSK Mielec whose business activities included the production and sale of fire trucks and served as its Vice-President from 1992 to 1994. He has been a Director of Leenlife Pharma International Inc. (also known as SPT - Sulphur Polymer Technologies Inc) since September 2015. He has been Director of Carbon Friendly Solutions, Inc. He served as Director of La Jolla Capital Inc since August 7, 2008 until June 17, 2015. He served as Director of Stream Communications Network & Media, Inc from February 25, 1994 to August 15, 2005 and Trooper Technologies Inc. from 1993 to 2000. He served as a Director of Net Soft Systems Inc. since June 2, 1999. In 1976, Mr. Lis had emigrated to Canada where he continued his studies at the Management and Administration Department, Business Administration and Securities at Simon Fraser University in Vancouver.

CEO Compensation
  • Stan's compensation has increased whilst company is loss making.
  • Stan's remuneration is higher than average for companies of similar size in Canada.
Management Team

Stan Lis

TITLE
CEO, President & Director
COMPENSATION
CA$355K
AGE
68
TENURE
4 yrs

Elizabeth Liu

TITLE
Chief Operating Officer
COMPENSATION
CA$72K
TENURE
1.5 yrs

Casey Forward

TITLE
Secretary
COMPENSATION
CA$355K
AGE
76

Dr. Hab Zajac

TITLE

Jason Tong

TITLE
Chief Financial Officer
AGE
35

Carl Perez

TITLE
Chief Technical Officer

Michael Young

TITLE
Head of Corporate Development
Board of Directors Tenure

Average tenure and age of the LeanLife Health board of directors in years:

4.2
Average Tenure
69
Average Age
  • The tenure for the LeanLife Health board of directors is about average.
Board of Directors

Stan Lis

TITLE
CEO, President & Director
COMPENSATION
CA$355K
AGE
68
TENURE
4.1 yrs

Glen MacDonald

TITLE
Director
AGE
70
TENURE
5.7 yrs

Marcin Lukaszewicz

TITLE
Director
TENURE
4.3 yrs

Robert Chanson

TITLE
Director
AGE
69
TENURE
0.7 yrs
Who owns this company?
Recent Insider Trading
  • No 3 month open market individual insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (CA$) Value (CA$)
X
Management checks
We assess LeanLife Health's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. LeanLife Health has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

LLP News

Simply Wall St News

Imagine Owning LeanLife Health (CNSX:LLP) While The Price Tanked 59%

See our latest analysis for LeanLife Health LeanLife Health didn't have any revenue in the last year, so it's fair to say it doesn't yet have a proven product (or at least not one people are paying for). … Investors will be hoping that LeanLife Health can make progress and gain better traction for the business, before it runs low on cash. … But with the share price diving 59% in the last year, it's probably fair to say that some shareholders no longer believe the company will succeed.

Simply Wall St -

Are LeanLife Health Inc's (CNSX:LLP) Interest Costs Too High?

Investors are always looking for growth in small-cap stocks like LeanLife Health Inc (CNSX:LLP), with a market cap of CA$3.76m. … However, an important fact which most ignore is: how financially healthy is the business? … the current state of its operations and pathway to profitability.

Simply Wall St -

LLP Company Info

Description

LeanLife Health Inc. produces and sells omega-3 fatty acid products in North America, Europe, and internationally. It offers its products in liquid, emulsion, or powder forms for use in baked goods, processed meats, noodles, beverages, milk products, and chocolates. The company was formerly known as LeenLife Pharma International Inc. and changed its name to LeanLife Health Inc. in January 2018. LeanLife Health Inc. was incorporated in 2014 and is headquartered in Vancouver, Canada.

Details
Name: LeanLife Health Inc.
LLP
Exchange: CNSX
Founded: 2014
CA$5,317,692
96,685,318
Website: http://www.leanlifehealth.com
Address: LeanLife Health Inc.
580 Hornby Street,
Suite 380,
Vancouver,
British Columbia, V6C 3B6,
Canada
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
CNSX LLP Common Shares Canadian National Stock Exchange CA CAD 04. Nov 2015
OTCPK LNLH.F Common Shares Pink Sheets LLC US USD 04. Nov 2015
DB LL1 Common Shares Deutsche Boerse AG DE EUR 04. Nov 2015
Number of employees
Current staff
Staff numbers
0
LeanLife Health employees.
Industry
Packaged Foods and Meats
Food, Beverage & Tobacco
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/09/15 01:11
End of day share price update: 2019/09/11 00:00
Last earnings filing: 2019/08/26
Last earnings reported: 2019/06/30
Last annual earnings reported: 2019/03/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.